The payer, which isn’t named, represents 837,000 patients across Utah and Idaho, according to a news release. Its policy provides coverage for patients with symptomatic degenerative disc disease who are treated with the Prodisc L.
Centinel Spine’s Prodisc L is the only total disc replacement system in the U.S. approved for two-level use in the lumbar spine.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
